ConductScience.org, home

Paper7604013

Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations.

Duan DR and 8 others. Proc Natl Acad Sci U S A, 1995. Cited by 128 papers, by iCite.

Cite this record

ConductScience Library. Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations. Papers, record 7604013. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7604013

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
1995
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
128
iCite
Relative citation ratio, by iCite
2.24
iCite
Revised in PubMed
2024-12-19
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Duan DRD R
2Humphrey JSJ S
3Chen DYD Y
4Weng YY
5Sukegawa JJ
6Lee SS
7Gnarra JRJ R
8Linehan WMW M
9Klausner RDR D

Source PubMed

Download CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Genes, Tumor SuppressorMajor topic
LigasesMajor topic
Nuclear ProteinsMajor topic
Tumor Suppressor ProteinsMajor topic
Ubiquitin-Protein LigasesMajor topic
von Hippel-Lindau DiseaseMajor topic
Amino Acid Sequence
Animals
Base Sequence
Cell Line
Chlorocebus aethiops
DNA, Complementary
HeLa Cells
Humans
Kidney
Molecular Sequence Data
Rats
Recombinant Proteins
Sequence Homology, Amino Acid
Sequence Homology, Nucleic Acid
Subcellular Fractions
Transfection
Von Hippel-Lindau Tumor Suppressor Protein

Source PubMed

Download CSV of topics

References14

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17728151Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.Hum Mutat1995https://conductscience.org/library/papers/7728151PubMed
22827008
SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat.
Mol Cell Biol1988https://conductscience.org/library/papers/2827008PubMed
31717476Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport.J Cell Biol1991https://conductscience.org/library/papers/1717476PubMed
48422679A nuclear pore complex protein that contains zinc finger motifs, binds DNA, and faces the nucleoplasm.Cell1993https://conductscience.org/library/papers/8422679PubMed
58436587Localization of TGN38 to the trans-Golgi network: involvement of a cytoplasmic tyrosine-containing sequence.J Cell Biol1993https://conductscience.org/library/papers/8436587PubMed
68493574Identification of the von Hippel-Lindau disease tumor suppressor gene.Science1993https://conductscience.org/library/papers/8493574PubMed
77850784
Cloning and characterization of a mouse gene with homology to the human von Hippel-Lindau disease tumor suppressor gene: implications for the potential organization of the human von Hippel-Lindau disease gene.
Cancer Res1995https://conductscience.org/library/papers/7850784PubMed
88187067Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.Cancer Res1994https://conductscience.org/library/papers/8187067PubMed
98193533Tumor suppressor genes.Curr Opin Genet Dev1994https://conductscience.org/library/papers/8193533PubMed
107915601Mutations of the VHL tumour suppressor gene in renal carcinoma.Nat Genet1994https://conductscience.org/library/papers/7915601PubMed
117937876Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.Proc Natl Acad Sci U S A1994https://conductscience.org/library/papers/7937876PubMed
127987306Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype.Hum Mol Genet1994https://conductscience.org/library/papers/7987306PubMed
137837390Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer.JAMA1995https://conductscience.org/library/papers/7837390PubMed
147902574Antioncogenes and human cancer.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/7902574PubMed

Download CSV of references

Cited by41

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 128 citations.

PMIDTitleJournalYearIn PapersSource
41526504Targeting and dissociating HIF2α from the molecular chaperone Hsp70 triggers apoptosis in kidney cancer.Commun Med (Lond)2026https://conductscience.org/library/papers/41526504PubMed
37477829Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategy.Cell Mol Life Sci2023https://conductscience.org/library/papers/37477829PubMed
36835292Role of SOCS and VHL Proteins in Neuronal Differentiation and Development.Int J Mol Sci2023https://conductscience.org/library/papers/36835292PubMed
35110537Deubiquitylase OTUD6B stabilizes the mutated pVHL and suppresses cell migration in clear cell renal cell carcinoma.Cell Death Dis2022https://conductscience.org/library/papers/35110537PubMed
29662541Cabozantinib in the treatment of advanced renal cell carcinoma in adults following prior vascular endothelial growth factor targeted therapy: clinical trial evidence and experience.Ther Adv Urol2018https://conductscience.org/library/papers/29662541PubMed
27620538William Kaelin, Peter Ratcliffe, and Gregg Semenza receive the 2016 Albert Lasker Basic Medical Research Award.J Clin Invest2016https://conductscience.org/library/papers/27620538PubMed
27155521Structure, function and regulation of jade family PHD finger 1 (JADE1).Gene2016https://conductscience.org/library/papers/27155521PubMed
26973240Phosphorylation-dependent cleavage regulates von Hippel Lindau proteostasis and function.Oncogene2016https://conductscience.org/library/papers/26973240PubMed
26323595A Novel von Hippel Lindau Gene Intronic Variant and Its Reclassification from VUS to Pathogenic: the Impact on a Large Family.J Genet Couns2015https://conductscience.org/library/papers/26323595PubMed
25310726Computational and experimental characterization of dVHL establish a Drosophila model of VHL syndrome.PLoS One2014https://conductscience.org/library/papers/25310726PubMed
24969085An integrated computational approach can classify VHL missense mutations according to risk of clear cell renal carcinoma.Hum Mol Genet2014https://conductscience.org/library/papers/24969085PubMed
23840444Structural insights into the folding defects of oncogenic pVHL lead to correction of its function in vitro.PLoS One2013https://conductscience.org/library/papers/23840444PubMed
22370733Pancreatic lesions in von Hippel-Lindau disease? A systematic review and meta-synthesis of the literature.J Gastrointest Surg2012https://conductscience.org/library/papers/22370733PubMed
20638985Characterization of the expression, localization, and secretion of PANDER in alpha-cells.Mol Cell Endocrinol2010https://conductscience.org/library/papers/20638985PubMed
18836774Computational detection of deleterious SNPs and their effect on sequence and structural level of the VHL gene.Mamm Genome2008https://conductscience.org/library/papers/18836774PubMed
18799446Neurologic manifestations of von Hippel-Lindau disease.JAMA2008https://conductscience.org/library/papers/18799446PubMed
18542780Current understanding of the molecular mechanisms of kidney cancer: a primer for urologists.Can Urol Assoc J2007https://conductscience.org/library/papers/18542780PubMed
18195360Allosteric effects in the marginally stable von Hippel-Lindau tumor suppressor protein and allostery-based rescue mutant design.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18195360PubMed
17526729Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations.Mol Cell Biol2007https://conductscience.org/library/papers/17526729PubMed
15904470A tumor-specific gene therapy strategy targeting dysregulation of the VHL/HIF pathway in renal cell carcinomas.Cancer Sci2005https://conductscience.org/library/papers/15904470PubMed

See all 41 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CDKN2A1029PubTator's text mininghttps://conductscience.org/library/genes/1029NCBI Gene
EXOSC811340PubTator's text mininghttps://conductscience.org/library/genes/11340NCBI Gene
VHL7428PubTator's text mininghttps://conductscience.org/library/genes/7428NCBI Gene

Download CSV of genes

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccession
GENBANKU14746

Source GENBANK

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7604013

GET https://conductscience.org/api/papers/v1/7604013/cited_by?page=2